Evidence map›Paper›PMID 27487330›Full record

ArticleNature immunology2016

CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles.

Yew Ann Leong, Yaping Chen, Hong Sheng Ong, Di Wu, Kevin Man, Claire Deleage, Martina Minnich, Benjamin J Meckiff, Yunbo Wei, Zhaohua Hou and 27 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 326 papers.

0numbers the graph read from it
0cells of the map it votes in
326citing papers in PubMed
23.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

326 citing papers in PubMed, 474 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Protein-dependent CD4iScience · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. HIV controllers, lessons learnt from the lymphoid tissues.Current opinion in HIV and AIDS · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. CD8Nature · 2026
    Article
  19. Regulators of CD8Nature reviews. Immunology · 2026
    Review
  20. Article

266 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 14 institutions in 5 countries.

Yew Ann LeongInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
Yaping ChenInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
Hong Sheng OngInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
Di WuSchool of Dentistry, The University of North Carolina at Chapel Hill, North Carolina, USA.
Kevin ManThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Claire DeleageAIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Martina MinnichResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Benjamin J MeckiffInstitute of Immunology and Immunotherapy, Centre for Human Virology and Cancer Immunology and Immunotherapy Centre, University of Birmingham, UK.
Yunbo WeiShandong Analysis and Test Center, Shandong Academy of Sciences, Jinan, China.
Zhaohua HouShandong Analysis and Test Center, Shandong Academy of Sciences, Jinan, China.
Dimitra ZotosThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Kevin A FenixDepartment of Molecular and Cellular Biology, School of Biological Sciences, University of Adelaide, Adelaide, Australia.
Anurag AtnerkarInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
Simon PrestonThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Jeffrey G ChipmanDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Greg J BeilmanDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Cody C AllisonThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Lei SunDepartment of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Peng WangDepartment of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Jiawei XuDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Jesse G ToeThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Hao K LuThe Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.
Yong TaoDepartment of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Umaimainthan PalendiraCentenary Institute, Newtown, Australia.
Alexander L DentDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Alan L LandayDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, Illinois, USA.
Marc PellegriniThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Iain ComerfordDepartment of Molecular and Cellular Biology, School of Biological Sciences, University of Adelaide, Adelaide, Australia.
Shaun R McCollDepartment of Molecular and Cellular Biology, School of Biological Sciences, University of Adelaide, Adelaide, Australia.
Timothy W SchackerDepartment of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Heather M LongInstitute of Immunology and Immunotherapy, Centre for Human Virology and Cancer Immunology and Immunotherapy Centre, University of Birmingham, UK.
Jacob D EstesAIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Meinrad BusslingerResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Gabrielle T BelzThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Sharon R LewinThe Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.
Axel KalliesThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Di YuInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.ORCID 0000-0003-1721-8922
The University of Melbourne · AUAustralian Regenerative Medicine Institute · AUCapital Medical University · CNThe University of Adelaide · AUUniversity of Minnesota · USLeidos (United States) · USResearch Institute of Molecular Pathology · ATShandong Academy of Sciences · CNThe Royal Melbourne Hospital · AUUniversity of Birmingham · GBUniversity of North Carolina at Chapel Hill · USCentenary Institute · AUIndiana University School of MedicineRush University Medical Center · US

Funding

Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
NCI NIH HHS HHSN261200800001ENIAID NIH HHS U19 AI096109
6 · The paper itself

Abstract

During unresolved infections, some viruses escape immunological control and establish a persistant reservoir in certain cell types, such as human immunodeficiency virus (HIV), which persists in follicular helper T cells (TFH cells), and Epstein-Barr virus (EBV), which persists in B cells. Here we identified a specialized group of cytotoxic T cells (TC cells) that expressed the chemokine receptor CXCR5, selectively entered B cell follicles and eradicated infected TFH cells and B cells. The differentiation of these cells, which we have called 'follicular cytotoxic T cells' (TFC cells), required the transcription factors Bcl6, E2A and TCF-1 but was inhibited by the transcriptional regulators Blimp1, Id2 and Id3. Blimp1 and E2A directly regulated Cxcr5 expression and, together with Bcl6 and TCF-1, formed a transcriptional circuit that guided TFC cell development. The identification of TFC cells has far-reaching implications for the development of strategies to control infections that target B cells and TFH cells and to treat B cell-derived malignancies.

Indexed as

AnimalsArenaviridae InfectionsBasic Helix-Loop-Helix ProteinsB-LymphocytesCell DifferentiationCells, CulturedEpstein-Barr Virus InfectionsGene Expression RegulationGerminal CenterHepatocyte Nuclear Factor 1-alphaHIVHumansLymphocytic choriomeningitis virusMaleMiceMice, Inbred C57BLBasic Helix-Loop-Helix ProteinsBcl6 protein, mouseCXCR5 protein, humanHepatocyte Nuclear Factor 1-alphaHnf1a protein, mousePositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseProto-Oncogene Proteins c-bcl-6Receptors, CXCR5Tcf3 protein, mouseTranscription Factors

Identifiers

PMID27487330
OpenAlexW2501034558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.